| Dr Nancy P Judd, MD | |
|
4921 Parkview Pl, Ste 11a, Saint Louis, MO 63110-1032 | |
| (314) 362-7509 | |
| (314) 362-7522 |
| Full Name | Dr Nancy P Judd |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 17 Years |
| Location | 4921 Parkview Pl, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093906315 | NPI | - | NPPES |
| 273851366 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 2010006159 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Pharmaxis has announced its first step into the Asian market, filing for Korean marketing approval of its lung function test Aridol.
Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
People are becoming more aware of what they put into their mouths and shifting from processed foods to natural and home-made foods. As for themselves they are more inclined to give their pet dogs these natural foods as well and are leaning towards a "raw meat" diet. These are often combined with pre-prepared foods that can be easily frozen and reheated for convenience.
› Verified 8 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Pharmaxis has announced its first step into the Asian market, filing for Korean marketing approval of its lung function test Aridol.
Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
People are becoming more aware of what they put into their mouths and shifting from processed foods to natural and home-made foods. As for themselves they are more inclined to give their pet dogs these natural foods as well and are leaning towards a "raw meat" diet. These are often combined with pre-prepared foods that can be easily frozen and reheated for convenience.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Pharmaxis has announced its first step into the Asian market, filing for Korean marketing approval of its lung function test Aridol.
Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
People are becoming more aware of what they put into their mouths and shifting from processed foods to natural and home-made foods. As for themselves they are more inclined to give their pet dogs these natural foods as well and are leaning towards a "raw meat" diet. These are often combined with pre-prepared foods that can be easily frozen and reheated for convenience.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1578638425 PECOS PAC ID: 3779495858 Enrollment ID: O20040805001280 |
News Archive
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Pharmaxis has announced its first step into the Asian market, filing for Korean marketing approval of its lung function test Aridol.
Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
People are becoming more aware of what they put into their mouths and shifting from processed foods to natural and home-made foods. As for themselves they are more inclined to give their pet dogs these natural foods as well and are leaning towards a "raw meat" diet. These are often combined with pre-prepared foods that can be easily frozen and reheated for convenience.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1073678637 PECOS PAC ID: 3779495858 Enrollment ID: O20100729000796 |
News Archive
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Pharmaxis has announced its first step into the Asian market, filing for Korean marketing approval of its lung function test Aridol.
Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
People are becoming more aware of what they put into their mouths and shifting from processed foods to natural and home-made foods. As for themselves they are more inclined to give their pet dogs these natural foods as well and are leaning towards a "raw meat" diet. These are often combined with pre-prepared foods that can be easily frozen and reheated for convenience.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1366781700 PECOS PAC ID: 3779495858 Enrollment ID: O20130507000207 |
News Archive
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Pharmaxis has announced its first step into the Asian market, filing for Korean marketing approval of its lung function test Aridol.
Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
People are becoming more aware of what they put into their mouths and shifting from processed foods to natural and home-made foods. As for themselves they are more inclined to give their pet dogs these natural foods as well and are leaning towards a "raw meat" diet. These are often combined with pre-prepared foods that can be easily frozen and reheated for convenience.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1497023188 PECOS PAC ID: 3779495858 Enrollment ID: O20131029000108 |
News Archive
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Pharmaxis has announced its first step into the Asian market, filing for Korean marketing approval of its lung function test Aridol.
Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
People are becoming more aware of what they put into their mouths and shifting from processed foods to natural and home-made foods. As for themselves they are more inclined to give their pet dogs these natural foods as well and are leaning towards a "raw meat" diet. These are often combined with pre-prepared foods that can be easily frozen and reheated for convenience.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy P Judd, MD 4921 Parkview Pl, Ste 11a, Saint Louis, MO 63110-1032 Ph: (314) 362-7509 | Dr Nancy P Judd, MD 4921 Parkview Pl, Ste 11a, Saint Louis, MO 63110-1032 Ph: (314) 362-7509 |
News Archive
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Pharmaxis has announced its first step into the Asian market, filing for Korean marketing approval of its lung function test Aridol.
Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
People are becoming more aware of what they put into their mouths and shifting from processed foods to natural and home-made foods. As for themselves they are more inclined to give their pet dogs these natural foods as well and are leaning towards a "raw meat" diet. These are often combined with pre-prepared foods that can be easily frozen and reheated for convenience.
› Verified 8 days ago
Mark F Stroble, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 12399 Gravois Rd, Ste 120, Saint Louis, MO 63127 Phone: 314-843-3828 Fax: 314-843-3052 | |
Arya W Namin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 607 S New Ballas Rd Ste 2300, Saint Louis, MO 63141 Phone: 314-251-6394 Fax: 314-251-4235 | |
Dr. Ethan Craig, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Dr. Richard A Chole, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Pl Ste 3s, Ste 3s, Saint Louis, MO 63110 Phone: 314-454-6162 Fax: 314-454-2174 | |
Dr. Timothy J Reichert, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 621 S New Ballas Rd, Suite 622a, Saint Louis, MO 63141 Phone: 314-872-8340 Fax: 314-872-8399 | |
Dr. Cameron Connelly Wick, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Dept Otolaryngology, Ste 11a, Saint Louis, MO 63110 Phone: 314-362-7509 Fax: 314-362-7522 | |
Dr. Matthew Lee Rohlfing, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Dept Otolaryngology, Ste 11a, Saint Louis, MO 63110 Phone: 314-362-7509 Fax: 314-362-7522 |